×

Govt actions unhelpful, MBS Review head admits

The hand-picked head of the Commonwealth’s Medicare Benefits Schedule Review has taken a veiled swipe at the Government over its handling of plans to axe 23 MBS items.

Confirming medical profession fears about the potential politicisation of the process, Professor Bruce Robinson told an AMA-hosted forum on the MBS Review that the taskforce co-ordinating the review had been given no say over a 28 December announcement by Health Minister Sussan Ley that an initial batch of 23 items had been recommended for removal from the MBS.

Professor Robinson told the forum, which was attended by representatives from almost 50 specialist colleges and societies, that the announcement was “something we did not have control over”.

In her announcement, Ms Ley said the items were obsolete and no longer consistent with clinical best-practice. The Government suggested axing them would save around $6.8 million a year.

But Professor Robinson cast doubt on the scale of savings from the measure, and lamented that the Government’s handling of the issue had tarnished medical profession support for the MBS review.

“The announcement was unfortunate, because it is one of those things that has caused criticism of the review process,” Professor Robinson said, adding that “those items to be deleted are not going to save much money; it’s a tidying up exercise.”

AMA President Professor Brian Owler told the forum, the second organised by the AMA, that the medical profession had taken part in the review with enthusiasm and goodwill, but that had been put at risk by the Minister’s post-Christmas announcement, as well as the Government’s unilateral action to unveil cuts to bulk billing incentives for pathology and diagnostic imaging services in the Mid-Year Economic and Fiscal Outlook (MYEFO).

“There’s a lot of goodwill within the medical profession to work with Professor Robinson and the Taskforce to improve the MBS. We all want a more modern MBS that reflects modern medical practice that is going to benefit patients,” Professor Owler said. “[But] if you engage the profession on that basis and then come out with an announcement in MYEFO, without any consultation or discussions…of course people are going to be upset.”

Dr Michael Harrison, from the Royal College of Pathologists of Australia, told Professor Robinson that the Government’s decision to axe bulk billing incentives for pathology services, taken without consultation, had “undermined the credibility of the [MBS] review”.

“Our confidence in the review has been severely affected,” he warned.

Much of the medical profession’s concern about the Medicare review has centred on doubts about its over-riding purpose.

Professor Robinson told the forum the focus was to modernise the MBS and align it with current clinical practice.

“My task is not to save money”, Professor Robinson said, and added that the taskforce did not have a savings target.

But the Government is intent on using the exercise to achieve savings, much of which will be used to help cut the Budget deficit. Ms Ley has indicated only half of any funds freed up as a result of the review will be re-invested in health.

Professor Owler acknowledged the review was like to deliver some savings (though probably not as many as the Government hoped), but warned the profession’s goodwill and support was contingent on any savings made were “held within health, to provide better services to patients”.

Adrian Rollins

Latest news:

Mind the gap

The head of the Federal Government’s MBS Review Taskforce has admitted there is “a bit of a risk” of a gap developing between the deletion of old Medicare items and the listing of up-to-date replacements.

In a frank assessment of the difficulties of modernising the MBS, Professor Bruce Robinson admitted there existed a tension between his taskforce and the Medical Services Advisory Committee (MSAC) over their respective roles in deleting and adding items to the Schedule.

The taskforce head said that while many of the clinicians who had volunteered to take part in the MBS review were impatient for change, the “extraordinarily rigorous” process used by MSAC in approving the listing of new services and procedures raised the prospect of a lengthy delay between the axing of an old item and its replacement by a new or updated one.

The issue was highlighted by AMA President Professor Brian Owler in his opening remarks to a forum on the MBS Review organised by the peak medical organisation.

Professor Owler warned of the risk that the Medicare review initiated by the Federal Government could result in an incomplete MBS unless the process to add new items to the schedule could be expedited.

“The concern is the ability of the MSAC process to deal with the number of recommendations that are going to be made – clearly there’s going to be quite a number to come out of this process – and the time it takes through that process before procedures are put on,” he said. “That means that you do have the potential for items to be taken away, and a potential gap before new items are put on.”

The source of concern is two-fold: that the meticulous MSAC approval process will result in lengthy delays in the listing of new items; and that the Health Minister, keen to hold down spending, will be reluctant to approve new items.

On the former, Professor Robinson questioned whether MSAC itself was becoming an obstacle to reform of the MBS, and needed an overhaul, or at least a significant change in approach.

“Is the MSAC process so rigorous that it is becoming an impediment to progress?” he asked.

The Minister has indicated that “no-brainer” changes that require a simple re-write should be expedited, but Professor Owler said consideration also needed to be given to fast-tracking clarifications or improvements that do not require a major MSAC review – an idea endorsed by Professor Robinson.

The MBS review taskforce head also sounded an optimistic note on the Government’s openness to listing new items.

Professor Robinson told the AMA forum that Health Minister Sussan Ley was now “more open to new MBS items than she was a few months ago”.

Adrian Rollins

Cheaper hips path to lower premiums

Private health funds are under pressure to pass any savings from reform of prosthetic pricing on to consumers through more modest premium increases.

As part of her push to improve the value of private health cover, Health Minister Sussan Ley has appointed experienced health administrator Professor Lloyd Samson to lead a working group examining the way medical implants and devices are priced.

The Industry Working Group on Prostheses, which includes a representative from the AMA, will look at current arrangements under which the cost of around 9000 prostheses and implants used in the private health system is set, resulting in prices that are often double or more of those paid in the public sector.

Ms Ley said the pricing process meant the same pacemaker delivered through the private system cost $26,000 – twice as much as if it was provided through a public hospital.

“It doesn’t matter whether it’s the hospital or the insurer purchasing these devices, the cost will always ultimately fall to the consumer, and I want to take unnecessary pressure off premiums,” the Minister said.

Under the current system, the price of a prosthesis is set and can only be under-cut if a rival device has more than 25 per cent of the market.

The focus on prosthesis pricing has come amid insistent warnings form the AMA about the quality of insurance policies on offer.

AMA President Professor Brian Owler has raised the alarm on the proliferation of policies with multiple exclusions and high excesses that often leave patients stranded without cover virtually at the surgery theatre door.

Professor Owler said it was particularly concerning that patients were often unaware that their cover had been downgraded, while others were being lured into buying “junk” policies that only provide cover in public hospitals.

The prostheses working group has been asked to look at ways to make the purchase of devices more competitive and efficient, and to ensure that the benefits of this are passed on to consumers.

Private health funds have long complained about the prices they are required to pay for prostheses, and estimate that up to $800 million a year could be saved by bringing prices more in to line with those paid in the public system.

The industry’s peak group, Private Healthcare Australia, said insurers spent $1.9 billion on prostheses last financial year – 14 per cent of total payouts.

The group said private patients in Australia paid far more for medical devices than those in comparable countries such as France, Japan and Italy, and much more than it cost the public sector.

“This is an unfair cost burden on private patients which the Government can address immediately,” PHA Chief Executive Dr Rachel David said, arguing for a system of reference pricing benchmarked against local and international charges.

But the Medical Technology Association of Australia said the price of medical devices had not changed in five years, and the growing payout reflected increased use of prostheses rather than cost.

The Association argued axing the current arrangement would cause chaos and take the power to decide what device a patient had from doctors and hand it to the health funds.

The Government’s review has also come under fire from smaller device manufacturers concerned that it will increase the market dominance of the big firms by allowing them to bundle overpriced routine products with devices only they can supply.

Changes to the pricing arrangement may also be resisted by some private hospital groups, which earn significant revenue from the supply and use of prosthetics.

The prosthesis review is taking place amid a broader assessment of the private health insurance system initiated by Ms Ley because of mounting consumer dissatisfaction with the value of private cover.

Ms Ley has asked health funds to resubmit plans for premium increases this year, based on their full financial position, rather than simply a tally of claims and benefits paid.

“Consumers have made it clear they don’t believe they’re getting value for money,” the Minister said.

Ms Ley said that claims and benefits constituted only part of the picture, “when we know insurers are holding an additional $5.1 billion capital in their pockets. The question I am asking insurers is: do they have some capacity to use this excess capital to deliver premium relief for their customers this year?”

The Samson review has been directed to report to the Minister in August.

Adrian Rollins

Privacy risk on Medicare outsourcing

The AMA has raised concerns that any move to outsourcing Medicare payments to the private sector could compromise patient privacy and further fragment their care.

Prime Minister Malcolm Turnbull has confirmed an overhaul of the Medicare payments system is under active consideration, with Health Minister Sussan Ley revealing the Health Department is investigating ways to digitise “transaction technology for payments”.

Though the Government has not explicitly said it is looking at outsourcing the payments system to the private sector, the AMA said such a move would be in keeping with the Commonwealth’s broader policy agenda to increasingly offload responsibility for funding and providing health care.

According to a report in the West Australian newspaper, the Government is well advanced in plans to outsource the processing of Medicare, Pharmaceutical Benefits Scheme and aged care claims and payments, as well as the administration of eligibility criteria.

The newspaper reported that the change was likely to be unveiled in the forthcoming Budget, with a call for tenders issued soon after.

It has been suggested that Australia Post, Telstra and the big banks, as well as overseas firms including Serco, Fuji-Xerox and Accenture, may bid for the work.

AMA Vice President Dr Stephen Parnis said such a move would raise serious privacy issues.

“There are concerns raised about the way that the administrators of these programs would handle confidential medical data; how their input may influence or undermine the doctor-patient relationship in terms of its funding,” Dr Parnis told ABC Radio.

He said it raised the prospect that a Medicare benefit item “might be administered, or potentially even refused, by someone who isn’t necessarily accountable to Government”. 

The outsourcing idea is the latest move by the Federal Government to change Medicare, after its failed attempts to introduce a GP co-payment, the institution of a four-year rebate freeze, a review of the Medicare Benefits Schedule, and cuts to bulk billing incentives for pathology and diagnostic imaging services.

But Mr Turnbull insisted that Government was “totally committed” to Medicare, and any change to its payments system was aimed at improving the service for consumers.

“What we are looking at, as we look at in every area, is improving the delivery of Government services, looking at ways to take the health and aged-care payment system into the 21st century,” the Prime Minister told Parliament. “This is about making it simpler and faster for patients to be able to transact with Medicare to get the services they are entitled to.”

Ms Ley said that “every day, Australians use cards to make ‘tap and go’ payments, and apps to make payments, and yet Medicare has not kept up with these new technologies”.

She said the Health Department was working with “business innovation and technology experts to determine the best and most up-to-date payment technologies available on the market for consumers and health and aged care service providers”.

The infrastructure of Medicare’s payments system is more than 30 years old, and although it processes more than 370 million patient rebates each year, the system’s age means it is becoming harder to add new types of payments.

The Opposition has slammed the outsourcing proposal, characterising it as an attempt to privatise Medicare, and there are concerns the policy would cause more than 1400 Department of Human Services workers involved in processing and payments to lose their jobs.

Adrian Rollins

 

Safe and legal medicinal pot just a vote away

Medicinal cannabis should become much more readily available under Federal Government plans to establish a single, national licensing scheme for the production and supply of the drug.

In an initiative cautiously welcomed by medical groups, Health Minister Sussan Ley has introduced legislation amending existing narcotics laws to allow for controlled cultivation of cannabis for medicinal and scientific purposes.

“For Australia, this is the missing piece in a patient’s journey,” Ms Ley said. “Importantly, having a safe, legal and reliable source of products will ensure medical practitioners are now at the centre of the decision-making process on whether medicinal cannabis may be beneficial for their patient”.

There are already provisions in place to allow for the legal production and distribution of medicinal cannabis, which can be prescribed by authorised specialists.

But demand significantly outstrips supply, making it difficult and expensive for patients to obtain.

Ms Ley said the legislation would provide “the missing piece in the puzzle” by improving the availability of the drug.

“I am confident [that] creating one single, nationally-consistent cultivation scheme…will not only help speed up the legislative and regulatory process but, ultimately, access to medicinal cannabis products as well,” the Minister said.

The AMA said its supports a nationally-consistent and evidence-based approach to the regulation, supply and use of medicinal cannabis.

In its submission to a Senate committee inquiry on the issue last year, the peak medical group said medicinal cannabis should be regulated in the same way as other therapeutic narcotic products, “in order to ensure it can be standardised and regulated in its pharmaceutical preparations and administration”, reducing potential harm to users.

Medicinal cannabis has been used to reduce the incidence of nausea and vomiting in chemotherapy patients, as an appetite stimulant, and as a treatment for chronic pain.

But AMA President Professor Brian Owler said last year that there needed to be a considered and evidence-based approach to its use.

“There are some conditions where it clearly may be beneficial, and perhaps we don’t need to have an in-depth trial on those sorts of indications. But there are clearly others where the evidence is actually not there,” Professor Owler said. “We need to have proper trials and regulate it as a medication just like any other medication.”

The Royal Australian College of Physicians said that although the move to establish a safe, legal and reliable national supply of the drug was welcome, significant details regarding who would be authorised to prescribe medicinal cannabis, and what appropriate dosages might be, were yet to be resolved.

“It still needs to be determined which type of medical specialist will be authorised to prescribe the drug,” College President Professor Nicholas Talley said. “And we also have reservations that there is still no standard dose of cannabis, and that dosage can vary according to condition.”

Ms Ley expects the legislation to have bipartisan support and to be passed in this session of Parliament.

Adrian Rollins

Cut jail time to build on Indigenous health gains

Soaring Indigenous imprisonment rates and a stubbornly wide life expectancy gap underline calls for the Federal Government to fully fund the National Aboriginal and Torres Strait Islander Health Plan.

AMA President Professor Brian Owler said the latest update on Indigenous health and welfare from the Close the Gap Steering Committee was “a mixed bag”, showing improvement on measures such as child mortality and year 12 attainment, but weak gains in others.

The report found the target to halve the gap in child mortality by 2018 was on track, supported by a lift in immunisation rates that has seen more Indigenous children vaccinated by age five compared with their non-Indigenous counterparts, and Indigenous mortality rates, particularly from heart disease and stroke, are declining.

But the gap in life expectancy is not narrowing fast enough to close by the Council of Australian Government’s 2031 target.

The Close the Gap report shows that between 2005 and 2012, the life expectancy of Indigenous men increased by 1.6 years to 69.1 years, and for Indigenous women 0.6 of a year to 73.7 years (the life expectancy of non-Indigenous men in 2012 was 79.7 year and women, 83.1 years).

But the report’s authors cautioned that the improvements were within the margin of error “and could, in fact, be non-existent”.

Indigenous life expectancy is improving at an annual rate of 0.32 years for men and 0.12 years for women, but the Steering Committee said this would have to increase to between 0.6 and 0.8 years annually to reach the 2030 target.

Driving much of the improvement has been a 40 per cent fall in deaths from heart attacks and strokes, and fatal respiratory illnesses have declined by 27 per cent.

Despite this, heart attacks a strokes remain a major killer, accounting for a quarter of all Indigenous deaths between 2008 and 2012, while suicide was the leading cause of death due to external causes.

“It is disappointing that the target to close the gap in life expectancy by 2031 is not on track,” Professor Owler said. “This is a clear signal that we have to put politics aside and work together to reach this important milestone. Above all, we need consistent funding and support from all governments.”

In his report on Closing the Gap, Prime Minister Malcolm Turnbull agreed that a more concerted effort was needed.

“As a nation, we are a work in progress, and closing the substantial gaps in outcomes between Aboriginal and Torres Strait Islander people and other Australians is one of our most important tasks,” Mr Turnbull said. “There has been encouraging progress…but it is undeniable that progress…has been variable.”

Professor Owler said that to make improved gains, the Federal Government should reverse Budget cuts to programs like the Indigenous Advancement Strategy and the Indigenous Australian Health Program, and commit to genuine engagement with Aboriginal community controlled health services.

Nonetheless, a rapid narrowing of the health gap for infants and young children gives hope that eventually it will narrow for adults as well.

Though the infant mortality rate for Indigenous infants is 1.7 times that of other Australians, it declined 64 per cent between 1998 and 2012, making the gap 83 per cent narrower.

Close the Gap Campaign Co-Chair Dr Jackie Huggins said the long term impact of such improvements were yet to be seen and would take time to measure. The report advised no measurable improvements should be expected before 2018.

Furthermore, Dr Huggins said, “this should not be cause for complacency, because the overall health of Aboriginal and Torres Strait Islander peoples still lags behind the rest of the nation”.

The Campaign backed the AMA in calling for governments to reduce Indigenous incarceration rates.

It warned the nation was on track to have a record 10,000 Indigenous people behind bars this year, which is described as “a grim milestone”.

An AMA report highlighted that imprisonment exacerbated serious health problems and Indigenous incarceration rates needed to be reduced if the country was to close the health gap.

Adrian Rollins

 

[Perspectives] Charlotte Watts: from pure maths to HIV and gender-based violence

Appointed last October as Chief Scientific Adviser to the UK Government’s Department for International Development (DFID), epidemiologist Charlotte Watts of the London School of Hygiene & Tropical Medicine (LSHTM) is, by training, a pure mathematician. Indeed, her PhD from the University of Warwick was titled “stochastic stability of diffeomorphisms”. Although a background in applied maths might have offered her a natural progression into statistics and epidemiology, the relevance to health of “diffeomorphisms” is harder to discern—although not, it seems, to Anne Mills, Professor of Health Economics and Policy at LSHTM.

[Comment] Offline: Stillbirths—the last great myth

Stillbirths are dismissed, stigmatised, and ignored by governments, media, and even health systems. Last week, a coalition of international researchers launched a new campaign to persuade political leaders to take stillbirths a great deal more seriously. The whole subject of stillbirths is bedevilled with myths. Stillbirths are not an important global health challenge? There are 2·6 million stillbirths annually, 1·3 million of which (horrifically) occur during labour. Stillbirths are inevitable? No, most causes of stillbirths (eg, infection, malnutrition) are entirely preventable.

Concerns persist over rural health fix

The Federal Government has rebuffed calls for an increase in the quota of medical students who come from rural backgrounds despite concerns initiatives to boost medical services in country areas will continue to fall short.

The Government has been accused of sending mixed messages on its rural medical workforce policy after using some of the funds freed up from cutting almost $600 million from health and aged care workforce spending to fund new programs intended to improve rural training opportunities.

It used its 2015-16 Mid Year Economic and Fiscal Outlook (MYEFO) to unveil a $93.8 million Integrated Rural Training Pipeline intended to improve the retention of postgraduate prevocational doctors in country areas.

The Pipeline includes the establishment of 30 regional training hubs (which will receive $14 million a year); at least $10 million a year for a Rural Junior Doctor Training Innovation Fund to foster new training approaches; and $16 million a year to fund up to an extra 100 places in the Specialist Training Program through to 2018.

Minister for Rural Health Fiona Nash said the funds for the initiative had been obtained by improving the targeting of existing health workforce programs and activities.

“The Australian Government invests more than $1 billion a year in programs to build the health workforce,” Senator Nash said, citing as an example the fact that, in 2014, almost 80 per cent of clinical placements were in metropolitan areas.

A further $130 million of health workforce spending is to be redirected into an expansion of the Rural Health Multidisciplinary Training program, with particular focus on addressing workforce shortages and increasing support for training in nursing, midwifery and allied health.

“Our objective is to provide the most effective support for health students to train in areas of need,” Senator Nash said.

But the impact of the announcement has been tempered by concerns that the overall effect of the changes is a net loss of funding for health workforce programs.

Health Minister Sussan Ley admitted as much when, in a statement released on 15 December, she confirmed that only a proportion of the $461.3 million the Government expects to save by “rationalising” existing workforce programs would go to fund the new initiatives, with the rest “being sensibly invested into Budget repair”.

Prior to the release of MYEFO, the AMA had urged the Government to make it mandatory that one in every three medical students be recruited from a rural background, and that the proportion required to undertake at last a year of clinical training in a rural area be increased from 25 to 33 per cent.

The AMA has welcomed the expansion of the Specialist Training Program, but President Professor Brian Owler said that country areas were still struggling to attract and retain sufficient locally-trained doctors despite record numbers of medical graduates.

“The ‘trickle down’ approach to solving workforce maldistribution is not working,” he said. “Australia has enough medical students, and the focus must now shift to how to better distribute the medical workforce.”

The AMA President said there was good evidence that medical students from a rural background, or those who undertook extended training in rural areas, were more likely to take up practice in the country upon graduation.

The AMA said less than 28 per cent of commencing domestic medical students came from a rural background, and recommended that the Government increase the current intake target from 25 to 33 per cent.

Professor Owler said significant action was needed, with a recent survey showing less than a quarter of domestic medical graduates lived outside the nation’s capital cities.

“The implementation of more ambitious targets may prove challenging in the short term, but there is evidence that this approach would be more successful in getting more young doctors living and working in rural Australia,” he said.

But the Government has so far resisted the suggestion.

Instead of increasing the rural medical student quota, universities have been directed to set their own targets for rural background students.

A Health Department spokesperson told Medical Observer that, even without a higher quota, a third of medical students in 2014 were of rural origin.

Adrian Rollins